Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System

Toxins (Basel). 2022 Apr 14;14(4):282. doi: 10.3390/toxins14040282.

Abstract

Various movement disorders, such as oromandibular dystonia, oral dyskinesia, bruxism, functional (psychogenic) movement disorder, and tremors, exist in the stomatognathic system. Most patients experiencing involuntary movements due to these disorders visit dentists or oral surgeons, who may be the first healthcare providers. However, differential diagnoses require neurological and dental knowledge. This study aimed to review scientific advances in botulinum toxin therapy for these conditions. The results indicated that botulinum toxin injection is effective and safe, with few side effects in most cases when properly administered by an experienced clinician. The diagnosis and treatment of movement disorders in the stomatognathic system require both neurological and dental or oral surgical knowledge and skills, and well-designed multicenter trials with a multidisciplinary team approach must be necessary to ensure accurate diagnosis and proper treatment.

Keywords: botulinum toxin therapy; bruxism; functional (psychogenic) movement disorder; oral dyskinesia; oromandibular dystonia; palatal tremor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Botulinum Toxins* / therapeutic use
  • Botulinum Toxins, Type A* / adverse effects
  • Dyskinesias* / drug therapy
  • Dystonia* / diagnosis
  • Dystonia* / drug therapy
  • Dystonic Disorders* / drug therapy
  • Humans
  • Movement Disorders* / drug therapy
  • Stomatognathic System

Substances

  • Botulinum Toxins
  • Botulinum Toxins, Type A